American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

UBX

UBX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

UBX historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of UBX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
UBX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
UBX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
UBX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in UBX holdings by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by UBX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Revolving Door

Former government officials who have lobbied for UBX

Quiver Logo

No former government officials on record as having lobbied for UBX

Revolving Door Dashboard
Corporate Lobbying

UBX Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

UBX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
UBX Income Statement
UBX Balance Sheet
UBX Cash Flow
U.S. Patents

New UBX patent grants

  • Patent Title: Treatment of a senescence-associated ocular disease or disorder using a bcl-xl selective inhibitor Apr. 29, 2025
  • Patent Title: Acyl sulfonamides that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer Feb. 11, 2025
  • Patent Title: Antibodies directed to tie-2 and methods of use Jan. 14, 2025
  • Patent Title: Methods of treating retinal vasculopathies Apr. 09, 2024
  • Patent Title: Methods of inhibiting pathological angiogenesis Jan. 09, 2024
  • Patent Title: Methods of inhibiting pathological angiogenesis Sep. 28, 2021
  • Patent Title: Acylsulfonamide derivatives for treating senescence-associated diseases and disorders Sep. 07, 2021
  • Patent Title: Acyl sulfonamides that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer Apr. 20, 2021
  • Patent Title: Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells Aug. 18, 2020
  • Patent Title: Phospholidines that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer Aug. 18, 2020
  • Patent Title: Phosphonamidates that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer Aug. 11, 2020
  • Patent Title: Acyl sulfonamides that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer Jul. 21, 2020
  • Patent Title: Acyl phosphonamidates and acyl benzylamines that are bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer Jul. 07, 2020
  • Patent Title: Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer Jun. 23, 2020
  • Patent Title: Technology to inhibit vascular changes that lead to vision loss in the eye Mar. 17, 2020
  • Patent Title: Composition comprising a gene vector that selectively depletes p16 positive senescent cells Feb. 04, 2020
  • Patent Title: Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer Dec. 31, 2019
  • Patent Title: Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (pi3k) inhibitor Dec. 31, 2019
  • Patent Title: Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss Nov. 19, 2019
  • Patent Title: Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye Nov. 19, 2019
  • Patent Title: Chemical entities that kill senescent cells for use in treating age-related disease Oct. 01, 2019
  • Patent Title: Replication conditional virus that specifically kills senescent cells Aug. 13, 2019
  • Patent Title: Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use Jun. 25, 2019
  • Patent Title: Use of sulfonamide inhibitors of bcl-2 and bcl-xl to treat ophthalmic disease by selectively removing senescent cells Jun. 25, 2019
  • Patent Title: Immunogenic compositions for inducing an immune response for elimination of senescent cells May. 07, 2019
  • Patent Title: Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen Apr. 16, 2019
  • Patent Title: Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population Feb. 26, 2019
  • Patent Title: Chemical entities that kill senescent cells for use in treating age-related disease Feb. 05, 2019
  • Patent Title: Treatment of joint pain Nov. 20, 2018
  • Patent Title: Treatment of ophthalmic conditions by selectively removing senescent cells from the eye Jul. 03, 2018
  • Patent Title: Treatment for osteoarthritis in a joint by administering a means for inhibiting mdm2 Jun. 12, 2018
  • Patent Title: Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use Jun. 05, 2018
  • Patent Title: Use of sulfonamide inhibitors of bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease May. 29, 2018
  • Patent Title: Drug conjugates for delivering compounds to senescent cells May. 15, 2018
  • Patent Title: Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline Jan. 02, 2018
  • Patent Title: Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells Dec. 26, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to UBX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
UBX News

Recent insights relating to UBX

CNBC Recommendations

Recent picks made for UBX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in UBX

UBX Analyst Ratings

UBX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
UBX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $UBX stock a Buy, Sell, or Hold?

  • What is the price target for $UBX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

UBX Top Shareholders
Shareholder
Shares Held
UBX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $UBX stock?

  • Who owns the most shares of $UBX stock?

  • What funds own $UBX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

UBX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view UBX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About UBX

No description available

UBX (UBX) Historical Stock Prices

UBX (UBX) closed at $0.2001 on July 8, 2025. Over the past year its adjusted close ranged from $0.2001 to $2.57. Daily prices go back to May 3, 2018, 1,804 trading days in all.

  • 1 month-70.62%
  • 3 months-77.35%
  • Year to date-79.51%
  • 1 year-84.95%
  • 3 years-66.65%
  • 5 years-97.46%
  • Max-98.80%
See every congressional and insider trade on the UBX price chart

Quiver Premium charts UBX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Jul 8, 2025 0.2824 0.3188 0.2000 0.2001 0.2001 3,847,602
Jul 7, 2025 0.2900 0.3171 0.2668 0.3005 0.3005 1,811,959
Jul 3, 2025 0.2950 0.3250 0.2809 0.2929 0.2929 1,167,077
Jul 2, 2025 0.3028 0.3393 0.2700 0.2980 0.2980 3,276,630
Jul 1, 2025 0.3320 0.4148 0.2410 0.3431 0.3431 14,919,881
Jun 30, 2025 0.7000 0.7200 0.3556 0.3841 0.3841 2,277,113
Jun 27, 2025 0.7800 0.7980 0.7714 0.7714 0.7714 54,343
Jun 26, 2025 0.7820 0.8215 0.7502 0.7850 0.7850 62,138
Jun 25, 2025 0.8150 0.8280 0.7623 0.7884 0.7884 128,554
Jun 24, 2025 0.7500 0.8098 0.7500 0.8000 0.8000 96,368
Jun 23, 2025 0.7697 0.8111 0.7500 0.7500 0.7500 170,366
Jun 20, 2025 0.8000 0.8285 0.8000 0.8050 0.8050 82,024
Jun 18, 2025 0.7800 0.8111 0.7800 0.7902 0.7902 125,352
Jun 17, 2025 0.8300 0.8490 0.7700 0.7760 0.7760 92,691
Jun 16, 2025 0.8000 0.8401 0.7700 0.8111 0.8111 113,675
Jun 13, 2025 0.8300 0.8559 0.7950 0.7980 0.7980 168,403
Jun 12, 2025 0.8600 0.8716 0.8016 0.8559 0.8559 134,256
Jun 11, 2025 0.8439 0.9683 0.8360 0.8795 0.8795 788,990
Jun 10, 2025 0.7200 1.13 0.7020 0.8100 0.8100 7,715,308
Jun 9, 2025 0.7000 0.7096 0.6855 0.6983 0.6983 109,900
Jun 6, 2025 0.6900 0.7080 0.6720 0.6810 0.6810 153,292
Jun 5, 2025 0.7200 0.7200 0.6880 0.6880 0.6880 113,416
Jun 4, 2025 0.7200 0.7300 0.7002 0.7224 0.7224 42,614
Jun 3, 2025 0.7163 0.7279 0.7004 0.7151 0.7151 99,227
Jun 2, 2025 0.7100 0.7198 0.7001 0.7163 0.7163 37,588
May 30, 2025 0.6900 0.6997 0.6614 0.6993 0.6993 179,977
May 29, 2025 0.7100 0.7100 0.6600 0.6800 0.6800 139,309
May 28, 2025 0.7623 0.7699 0.6800 0.6810 0.6810 245,761
May 27, 2025 0.7790 0.7957 0.7250 0.7379 0.7379 325,394
May 23, 2025 0.7697 0.8099 0.7500 0.7790 0.7790 72,210
May 22, 2025 0.7700 0.7800 0.7300 0.7699 0.7699 160,244
May 21, 2025 0.7600 0.8203 0.7369 0.7369 0.7369 227,762
May 20, 2025 0.8029 0.8470 0.7704 0.7749 0.7749 108,307
May 19, 2025 0.8350 0.8500 0.7801 0.8091 0.8091 136,043
May 16, 2025 0.7900 0.8450 0.7791 0.8196 0.8196 99,635
May 15, 2025 0.7330 0.7870 0.7200 0.7610 0.7610 202,471
May 14, 2025 0.8067 0.8300 0.7331 0.7450 0.7450 219,547
May 13, 2025 0.8804 0.9220 0.7003 0.8100 0.8100 581,576
May 12, 2025 0.9500 0.9500 0.8710 0.9021 0.9021 176,004
May 9, 2025 0.9048 0.9312 0.8754 0.9141 0.9141 82,513
May 8, 2025 0.8900 0.9140 0.8701 0.9099 0.9099 92,999
May 7, 2025 0.9600 0.9680 0.8600 0.8929 0.8929 373,951
May 6, 2025 1.07 1.10 0.9101 0.9200 0.9200 232,471
May 5, 2025 1.08 1.23 1.06 1.07 1.07 185,557
May 2, 2025 1.14 1.14 1.10 1.12 1.12 74,435
May 1, 2025 1.17 1.17 1.10 1.10 1.10 71,140
Apr 30, 2025 0.9928 1.18 0.9800 1.13 1.13 123,355
Apr 29, 2025 1.00 1.03 0.9880 1.01 1.01 41,593
Apr 28, 2025 0.9700 0.9999 0.9700 0.9808 0.9808 48,346
Apr 25, 2025 1.00 1.04 0.9760 0.9770 0.9770 88,145
Apr 24, 2025 1.01 1.02 0.9256 0.9837 0.9837 96,822
Apr 23, 2025 1.02 1.03 0.9700 0.9860 0.9860 73,296
Apr 22, 2025 0.9400 1.01 0.9400 0.9820 0.9820 44,552
Apr 21, 2025 0.9700 0.9700 0.9102 0.9397 0.9397 128,312
Apr 17, 2025 0.9710 0.9999 0.9200 0.9700 0.9700 35,796
Apr 16, 2025 0.9972 1.03 0.9500 0.9520 0.9520 68,197
Apr 15, 2025 0.9700 1.03 0.9650 0.9700 0.9700 62,064
Apr 14, 2025 0.9857 1.07 0.9620 0.9700 0.9700 179,735
Apr 11, 2025 0.9500 1.02 0.9304 0.9896 0.9896 60,102
Apr 10, 2025 0.9500 0.9600 0.9213 0.9598 0.9598 81,015
Apr 9, 2025 0.9100 0.9670 0.9000 0.9600 0.9600 113,879
Apr 8, 2025 1.05 1.07 0.8531 0.8833 0.8833 258,167
Apr 7, 2025 0.8730 0.9716 0.8600 0.9251 0.9251 121,876
Apr 4, 2025 1.00 1.00 0.8817 0.9000 0.9000 211,142
Apr 3, 2025 1.03 1.04 0.9800 0.9900 0.9900 123,712
Apr 2, 2025 0.9800 1.09 0.9500 1.06 1.06 391,291
Apr 1, 2025 1.05 1.06 0.9500 0.9601 0.9601 271,659
Mar 31, 2025 1.20 1.22 1.01 1.04 1.04 254,168
Mar 28, 2025 1.17 1.21 1.09 1.14 1.14 134,591
Mar 27, 2025 1.21 1.24 1.10 1.18 1.18 248,137
Mar 26, 2025 1.27 1.27 1.20 1.20 1.20 131,805
Mar 25, 2025 1.30 1.34 1.24 1.26 1.26 176,241
Mar 24, 2025 1.38 1.39 1.16 1.30 1.30 1,963,140
Mar 21, 2025 1.69 1.85 1.69 1.82 1.82 53,497
Mar 20, 2025 1.75 1.80 1.70 1.70 1.70 44,893
Mar 19, 2025 1.74 1.80 1.70 1.79 1.79 73,609
Mar 18, 2025 1.76 1.79 1.68 1.74 1.74 58,090
Mar 17, 2025 1.78 1.80 1.69 1.75 1.75 48,707
Mar 14, 2025 1.79 1.82 1.73 1.77 1.77 109,502
Mar 13, 2025 1.89 1.89 1.68 1.79 1.79 58,644
Mar 12, 2025 1.73 1.98 1.73 1.78 1.78 251,540
Mar 11, 2025 1.58 1.73 1.57 1.72 1.72 133,660
Mar 10, 2025 1.60 1.75 1.53 1.60 1.60 161,788
Mar 7, 2025 1.74 1.79 1.60 1.68 1.68 50,265
Mar 6, 2025 1.68 1.79 1.65 1.76 1.76 88,451
Mar 5, 2025 1.66 1.74 1.66 1.70 1.70 47,186
Mar 4, 2025 1.53 1.70 1.48 1.69 1.69 142,895
Mar 3, 2025 1.72 1.76 1.54 1.55 1.55 83,486
Feb 28, 2025 1.60 1.73 1.50 1.71 1.71 118,813
Feb 27, 2025 1.81 1.93 1.63 1.64 1.64 92,185
Feb 26, 2025 1.63 1.78 1.63 1.72 1.72 83,362
Feb 25, 2025 1.80 1.84 1.58 1.65 1.65 282,275
Feb 24, 2025 1.98 2.11 1.80 1.81 1.81 193,968
Feb 21, 2025 2.05 2.13 1.94 1.94 1.94 99,438
Feb 20, 2025 2.07 2.17 2.00 2.05 2.05 39,363
Feb 19, 2025 2.02 2.13 1.99 2.05 2.05 57,260
Feb 18, 2025 2.30 2.33 2.00 2.02 2.02 150,702
Feb 14, 2025 2.00 2.25 2.00 2.19 2.19 198,134
Feb 13, 2025 1.94 2.02 1.89 1.98 1.98 128,000
Feb 12, 2025 1.91 2.03 1.83 1.94 1.94 175,211
Feb 11, 2025 2.12 2.13 1.81 2.04 2.04 323,264
Feb 10, 2025 2.15 2.32 2.02 2.04 2.04 254,290
Feb 7, 2025 2.26 2.35 2.08 2.14 2.14 200,671
Feb 6, 2025 2.31 2.39 2.22 2.26 2.26 136,559
Feb 5, 2025 2.23 2.34 2.23 2.30 2.30 126,894
Feb 4, 2025 2.15 2.33 2.15 2.23 2.23 106,613
Feb 3, 2025 2.18 2.39 2.05 2.17 2.17 146,756
Jan 31, 2025 2.15 2.42 2.14 2.22 2.22 199,300
Jan 30, 2025 2.27 2.35 2.02 2.14 2.14 204,952
Jan 29, 2025 2.26 2.42 2.15 2.24 2.24 116,803
Jan 28, 2025 2.38 2.45 2.20 2.25 2.25 241,279
Jan 27, 2025 2.01 2.28 2.00 2.15 2.15 488,626
Jan 24, 2025 2.70 2.85 2.31 2.38 2.38 672,643
Jan 23, 2025 2.19 3.10 2.17 2.57 2.57 2,080,064
Jan 22, 2025 1.81 2.20 1.80 2.09 2.09 537,778
Jan 21, 2025 1.75 1.84 1.73 1.79 1.79 210,407
Jan 17, 2025 1.71 1.75 1.66 1.73 1.73 124,586
Jan 16, 2025 1.67 1.70 1.61 1.69 1.69 138,386
Jan 15, 2025 1.73 1.77 1.56 1.69 1.69 230,751
Jan 14, 2025 1.72 1.81 1.61 1.71 1.71 340,131
Jan 13, 2025 1.78 1.85 1.63 1.72 1.72 340,358
Jan 10, 2025 1.41 1.80 1.37 1.79 1.79 749,208
Jan 8, 2025 1.64 1.64 1.24 1.33 1.33 459,888
Jan 7, 2025 1.78 1.98 1.74 1.81 1.81 410,071
Jan 6, 2025 1.35 1.97 1.35 1.78 1.78 1,591,960
Jan 3, 2025 1.17 1.33 1.16 1.28 1.28 391,086
Jan 2, 2025 1.01 1.20 1.01 1.14 1.14 293,398
Dec 31, 2024 0.9400 1.00 0.9397 0.9764 0.9764 98,869
Dec 30, 2024 0.9900 1.00 0.9443 0.9604 0.9604 134,963
Dec 27, 2024 1.05 1.08 0.9954 0.9990 0.9990 131,611
Dec 26, 2024 1.00 1.05 0.9700 1.03 1.03 104,331
Dec 24, 2024 0.9935 1.00 0.9800 1.00 1.00 34,496
Dec 23, 2024 0.9598 1.02 0.9598 0.9997 0.9997 121,247
Dec 20, 2024 0.9505 0.9950 0.9468 0.9598 0.9598 121,018
Dec 19, 2024 1.03 1.03 0.9500 0.9699 0.9699 123,842
Dec 18, 2024 1.03 1.03 1.00 1.00 1.00 137,420
Dec 17, 2024 1.05 1.06 1.02 1.02 1.02 125,113
Dec 16, 2024 1.11 1.12 1.07 1.08 1.08 122,598
Dec 13, 2024 1.11 1.14 1.11 1.12 1.12 67,816
Dec 12, 2024 1.16 1.18 1.10 1.11 1.11 86,321
Dec 11, 2024 1.15 1.18 1.11 1.14 1.14 94,317
Dec 10, 2024 1.18 1.19 1.15 1.17 1.17 48,534
Dec 9, 2024 1.21 1.21 1.17 1.20 1.20 79,546
Dec 6, 2024 1.19 1.22 1.15 1.19 1.19 89,898
Dec 5, 2024 1.11 1.23 1.10 1.19 1.19 109,484
Dec 4, 2024 1.19 1.19 1.10 1.12 1.12 133,562
Dec 3, 2024 1.22 1.23 1.11 1.13 1.13 173,287
Dec 2, 2024 1.23 1.25 1.21 1.23 1.23 99,726
Nov 29, 2024 1.22 1.25 1.21 1.24 1.24 49,724
Nov 27, 2024 1.25 1.25 1.19 1.21 1.21 30,597
Nov 26, 2024 1.19 1.22 1.17 1.21 1.21 65,647
Nov 25, 2024 1.17 1.20 1.16 1.19 1.19 51,231
Nov 22, 2024 1.17 1.18 1.13 1.14 1.14 56,995
Nov 21, 2024 1.15 1.17 1.14 1.16 1.16 51,730
Nov 20, 2024 1.17 1.19 1.14 1.17 1.17 53,339
Nov 19, 2024 1.19 1.19 1.15 1.16 1.16 60,643
Nov 18, 2024 1.23 1.24 1.15 1.19 1.19 58,862
Nov 15, 2024 1.25 1.29 1.19 1.21 1.21 48,922
Nov 14, 2024 1.35 1.35 1.25 1.26 1.26 63,935
Nov 13, 2024 1.33 1.35 1.30 1.31 1.31 65,625
Nov 12, 2024 1.24 1.37 1.19 1.32 1.32 109,489
Nov 11, 2024 1.20 1.25 1.17 1.25 1.25 159,019
Nov 8, 2024 1.18 1.20 1.15 1.17 1.17 72,023
Nov 7, 2024 1.16 1.20 1.14 1.18 1.18 124,361
Nov 6, 2024 1.24 1.24 1.10 1.15 1.15 169,692
Nov 5, 2024 1.15 1.25 1.12 1.21 1.21 113,151
Nov 4, 2024 1.33 1.34 1.24 1.26 1.26 133,131
Nov 1, 2024 1.37 1.38 1.30 1.31 1.31 64,252
Oct 31, 2024 1.38 1.40 1.32 1.36 1.36 26,701
Oct 30, 2024 1.40 1.40 1.38 1.38 1.38 24,002
Oct 29, 2024 1.40 1.40 1.36 1.40 1.40 33,390
Oct 28, 2024 1.35 1.40 1.34 1.40 1.40 31,376
Oct 25, 2024 1.33 1.36 1.33 1.34 1.34 40,610
Oct 24, 2024 1.40 1.40 1.31 1.32 1.32 69,909
Oct 23, 2024 1.39 1.39 1.34 1.37 1.37 56,726
Oct 22, 2024 1.40 1.40 1.38 1.40 1.40 11,791
Oct 21, 2024 1.40 1.40 1.38 1.40 1.40 19,028
Oct 18, 2024 1.37 1.40 1.37 1.40 1.40 27,193
Oct 17, 2024 1.41 1.41 1.35 1.38 1.38 84,716
Oct 16, 2024 1.40 1.44 1.40 1.42 1.42 66,668
Oct 15, 2024 1.47 1.48 1.39 1.40 1.40 102,443
Oct 14, 2024 1.51 1.51 1.46 1.46 1.46 49,021
Oct 11, 2024 1.47 1.53 1.44 1.50 1.50 78,696
Oct 10, 2024 1.48 1.48 1.45 1.46 1.46 12,472
Oct 9, 2024 1.49 1.53 1.45 1.48 1.48 25,543
Oct 8, 2024 1.48 1.54 1.48 1.49 1.49 29,553
Oct 7, 2024 1.46 1.50 1.45 1.49 1.49 32,597
Oct 4, 2024 1.43 1.47 1.42 1.46 1.46 41,612
Oct 3, 2024 1.43 1.46 1.43 1.44 1.44 11,206
Oct 2, 2024 1.44 1.47 1.43 1.43 1.43 14,047
Oct 1, 2024 1.46 1.47 1.44 1.44 1.44 11,567
Sep 30, 2024 1.46 1.47 1.42 1.47 1.47 43,865
Sep 27, 2024 1.47 1.48 1.44 1.45 1.45 15,399
Sep 26, 2024 1.45 1.45 1.43 1.44 1.44 22,954
Sep 25, 2024 1.44 1.45 1.42 1.43 1.43 16,266
Sep 24, 2024 1.43 1.47 1.42 1.44 1.44 26,432
Sep 23, 2024 1.46 1.46 1.41 1.44 1.44 27,385
Sep 20, 2024 1.44 1.46 1.41 1.45 1.45 61,917
Sep 19, 2024 1.45 1.48 1.43 1.44 1.44 20,833
Sep 18, 2024 1.44 1.45 1.42 1.42 1.42 28,254
Sep 17, 2024 1.41 1.44 1.40 1.42 1.42 25,879
Sep 16, 2024 1.45 1.46 1.40 1.41 1.41 23,744
Sep 13, 2024 1.41 1.48 1.39 1.44 1.44 46,696
Sep 12, 2024 1.41 1.44 1.40 1.40 1.40 33,649
Sep 11, 2024 1.39 1.42 1.39 1.40 1.40 27,477
Sep 10, 2024 1.46 1.46 1.39 1.41 1.41 23,678
Sep 9, 2024 1.42 1.46 1.40 1.44 1.44 63,654
Sep 6, 2024 1.53 1.53 1.44 1.45 1.45 37,366
Sep 5, 2024 1.53 1.60 1.51 1.52 1.52 27,950
Sep 4, 2024 1.56 1.64 1.50 1.54 1.54 48,869
Sep 3, 2024 1.63 1.64 1.55 1.55 1.55 26,093
Aug 30, 2024 1.67 1.68 1.62 1.63 1.63 29,403
Aug 29, 2024 1.66 1.67 1.64 1.66 1.66 67,257
Aug 28, 2024 1.68 1.69 1.66 1.67 1.67 32,089
Aug 27, 2024 1.71 1.72 1.67 1.67 1.67 64,973
Aug 26, 2024 1.58 1.74 1.57 1.72 1.72 121,077
Aug 23, 2024 1.55 1.58 1.53 1.57 1.57 46,231
Aug 22, 2024 1.57 1.57 1.53 1.53 1.53 65,574
Aug 21, 2024 1.50 1.54 1.48 1.53 1.53 51,861
Aug 20, 2024 1.48 1.53 1.47 1.51 1.51 28,682
Aug 19, 2024 1.42 1.48 1.39 1.48 1.48 133,573
Aug 16, 2024 1.41 1.43 1.39 1.42 1.42 47,966
Aug 15, 2024 1.45 1.46 1.41 1.41 1.41 29,581
Aug 14, 2024 1.46 1.47 1.45 1.45 1.45 47,762
Aug 13, 2024 1.46 1.50 1.45 1.47 1.47 11,457
Aug 12, 2024 1.47 1.53 1.44 1.47 1.47 29,331
Aug 9, 2024 1.46 1.46 1.44 1.44 1.44 19,457
Aug 8, 2024 1.40 1.48 1.37 1.48 1.48 51,221
Aug 7, 2024 1.39 1.44 1.39 1.41 1.41 21,729
Aug 6, 2024 1.36 1.41 1.36 1.39 1.39 20,414
Aug 5, 2024 1.40 1.42 1.35 1.35 1.35 64,307
Aug 2, 2024 1.53 1.55 1.45 1.46 1.46 59,463
Aug 1, 2024 1.51 1.55 1.50 1.54 1.54 47,105
Jul 31, 2024 1.48 1.53 1.45 1.53 1.53 45,812
Jul 30, 2024 1.45 1.49 1.41 1.49 1.49 27,599
Jul 29, 2024 1.48 1.49 1.41 1.45 1.45 33,040
Jul 26, 2024 1.48 1.51 1.45 1.47 1.47 31,220
Jul 25, 2024 1.43 1.48 1.43 1.44 1.44 22,082
Jul 24, 2024 1.45 1.47 1.43 1.45 1.45 20,128
Jul 23, 2024 1.51 1.51 1.42 1.46 1.46 35,835
Jul 22, 2024 1.45 1.51 1.44 1.47 1.47 24,079
Jul 19, 2024 1.48 1.50 1.44 1.45 1.45 14,182
Jul 18, 2024 1.52 1.52 1.46 1.47 1.47 40,070
Jul 17, 2024 1.57 1.57 1.49 1.51 1.51 66,422
Jul 16, 2024 1.58 1.58 1.51 1.54 1.54 39,187
Jul 15, 2024 1.55 1.57 1.53 1.56 1.56 46,041
Jul 12, 2024 1.49 1.58 1.49 1.55 1.55 73,274
Jul 11, 2024 1.50 1.50 1.43 1.47 1.47 55,154
Jul 10, 2024 1.43 1.47 1.40 1.45 1.45 60,915
Jul 9, 2024 1.34 1.43 1.33 1.43 1.43 68,974
Jul 8, 2024 1.33 1.33 1.28 1.33 1.33 40,504

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
UBX Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at UBX, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation